99.3% PURITY
NOOTROPIC NEUROPEPTIDE
Semax
10 mg vial · lyophilized
A synthetic heptapeptide derived from ACTH (4-10), developed in Russia and listed on its essential-medicines registry for stroke recovery. Widely studied as a nootropic for BDNF modulation and neuroprotection.
Half-Life
~30 minutes systemic (CNS effects last hours)
Storage
Lyophilized: 2–8 °C. Reconstituted: 2–8 °C, use within 30 days.
A synthetic heptapeptide derived from ACTH (4-10), developed in Russia and listed on its essential-medicines registry for stroke recovery. Widely studied as a nootropic for BDNF modulation and neuroprotection.
View Certificate of Analysis (COA)Who it's for
Cognitive-performance researchers studying BDNF / NGF modulation, focus, and neuroprotection.
Key things to know
- •Intranasal administration provides rapid CNS uptake.
- •Effects appear within 30–90 minutes — cognitive task pairing is common.
- •Cycle 4–6 weeks on, 2 weeks off to preserve receptor responsiveness.
- •Pairs well with Selank for combined focus + anxiolytic profiles.
Research Highlights
- •Used clinically in Russia for acute ischemic stroke and cognitive disorders
- •Multiple studies show BDNF elevation within 90 minutes of administration
